EUVIMEDPoznaj EUVIMED
Randomisierte kontrollierte StudieStudienprotokollOpen access

Treatment of Erythematotelangiectatic Rosacea With Collateral Puncture Therapy: Protocol for a Randomized Controlled Trial

Aolin Song iD, Bingnan Cui iD, Xuemin Wang iD, Jianing Bi iD, Xiaohong Wu iD, Liu Yang iD, Li Liu iD, Shengyuan Qu iD, Zhu Fan iD, Jiao Yang iD, Yuhe Yan iD

JMIR Research Protocols · 2025

DOI: 10.2196/59682 ↗

At a glance

Randomisierte kontrollierte Studie in JMIR Research Protocols, 2025. Written by Aolin Song and 10 co-authors. Institution: Department of Dermatology, Guang'anmen Hospital, Beijing, China. Major MEDLINE topics: Rosacea, Punctures, Acupuncture Therapy. Cited 2 times so far (Crossref); 35 references. The full text is freely available in PubMed Central.

AbstraktSubjectsDane bibliograficzneCiteRelated studies

Abstract (original language)

Background

Erythematotelangiectatic rosacea (ETR) is the most common subtype of rosacea, characterized by persistent facial erythema and telangiectasia of varying calibers. It causes significant aesthetic impairment and is often accompanied by uncomfortable symptoms, such as burning, stinging, dryness, and itching, profoundly affecting patients’ quality of life. Intense pulsed light (IPL) therapy demonstrates notable improvement in persistent erythema and telangiectasia; however, it is associated with issues such as a prolonged treatment course and high costs. Collateral puncture therapy involves rapid puncturing of specific acupuncture points followed by gentle squeezing around the needle holes to induce minor bleeding. Previous studies have shown that collateral puncture therapy for ETR offers advantages such as rapid onset of effect, a simple procedure, and low cost. Nevertheless, more high-quality clinical research data are needed to confirm these findings.

Objective

This study aims to observe the clinical efficacy and safety of collateral puncture therapy in treating ETR.

Methods

This study enrolled 60 patients diagnosed with ETR. The patients were randomly divided into 2 groups: one group underwent 4 sessions of collateral puncture therapy with 1-week intervals between treatments, and the other group received a single session of IPL therapy. The primary efficacy end points were the clinician’s erythema assessment and the clinician’s telangiectasia assessment. The secondary efficacy end points included the investigator’s global assessment, patient’s self-assessment, Flushing Assessment Tool results, Dermatology Life Quality Index, and Rosacea-specific Quality-of-Life instrument. The evaluation points were before treatment, immediately after treatment, and during follow-up. The data were statistically analyzed using SPSS (version 25.0; IBM Corp) to compare intragroup and intergroup differences between the 2 sets of data before and after treatment, with a significance level of α=.05 for hypothesis testing.

Results

Recruitment began on June 1, 2023. All participants have been recruited. Data analysis will be complete by the end of August 2025, with study findings available by December 2025.

Conclusions

This study has the potential to verify the clinical efficacy and safety of collateral puncture therapy in the treatment of ETR, supplement rosacea treatment methods, standardize treatment protocols, and fill a current clinical gap in treating rosacea. Trial Registration Chinese Clinical Trial Registry ChiCTR2200062639; https://www.chictr.org.cn/showproj.html?proj=177100 International Registered Report Identifier (IRRID) DERR1-10.2196/59682

Subjects

MeSH terms (MEDLINE)

RosaceaPuncturesAcupuncture TherapyHumansFemaleQuality of LifeMaleAdultTreatment OutcomeMiddle AgedRandomized Controlled Trials as Topic

Author keywords

collateral punctureerythematotelangiectatic rosaceaintense pulsed lightprotocolrandomized controlled trial

Authors and institutions

  • Department of Dermatology, Guang'anmen Hospital, Beijing, China.
  • Traditional Chinese Medicine Department, Shanghai Skin Disease Hospital, Shanghai, China.

ORCID profiles: Aolin Song, Bingnan Cui, Xuemin Wang, Jianing Bi, Xiaohong Wu, Liu Yang, Li Liu, Shengyuan Qu, Zhu Fan, Jiao Yang, Yuhe Yan

Cite

APA

Song, A., Cui, B., Wang, X., Bi, J., Wu, X., Yang, L., Liu, L., Qu, S., Fan, Z., Yang, J., & Yan, Y. (2025). Treatment of Erythematotelangiectatic Rosacea With Collateral Puncture Therapy: Protocol for a Randomized Controlled Trial. JMIR Research Protocols. https://doi.org/10.2196/59682

Vancouver

Song A, Cui B, Wang X, Bi J, Wu X, Yang L, et al. Treatment of Erythematotelangiectatic Rosacea With Collateral Puncture Therapy: Protocol for a Randomized Controlled Trial. JMIR Research Protocols. 2025. doi:10.2196/59682

BibTeX
@article{Song2025,
  author = {Song, Aolin and Cui, Bingnan and Wang, Xuemin and Bi, Jianing and Wu, Xiaohong and Yang, Liu and Liu, Li and Qu, Shengyuan and Fan, Zhu and Yang, Jiao and Yan, Yuhe},
  title = {Treatment of Erythematotelangiectatic Rosacea With Collateral Puncture Therapy: Protocol for a Randomized Controlled Trial},
  journal = {JMIR Research Protocols},
  year = {2025},
  doi = {10.2196/59682}
}
Start for free →